Show
Sort by
-
Integration of oncology and palliative care: summary of the Lancet Oncology Commission Paper.
-
Molecular test algorithms for breast tumours
-
Difficulties in diagnosis and treatment of a rare malignancy, malignant peritoneal mesothelioma
-
Algorithms for molecular testing in solid tumours
-
The strategic plan for paediatric cancer treatment in Belgium
-
PD-L1 testing for non-small cell lung cancer : Belgian guidelines
-
Pharmacological restoration of tumour suppressor protein p53 in neuroblastoma : seeking synergy and non-invasive biomarkers
-
MRI in prostate cancer diagnosis, surgical or radiation treatment, focal therapy, active surveillance and follow-up
-
Chalcones as anti-invasive agents : challenges and opportunities
-
Extracellular vesicles to diagnose and treat cancer
-
The ION-Ghent guidelines for the management of immune related adverse events (irAE's)
-
Pathological diagnosis and molecular testing in non-small cell lung cancer: Belgian guidelines
-
Radiation-induced collateral damage : impact on metastasis
-
Congress highlights: ASCO 2015 special edition: highlights in genitourinary cancers from the 2015 ASCO annual meeting
-
Congress highlights: ECCO-ESMO 2015 special edition: highlights in genitourinary cancers from the 18th ECCO – 40th ESMO European cancer congress
-
Second Belgian multidisciplinary meeting on urological cancers held in Brussels, March 28th, 2015
-
Mixed adenoneuroendocrine carcinoma (MANEC) of the colon : molecular pathogenesis and treatment
-
RAS-testing in colorectal cancer : Belgian guidelines
-
Congress highlights: first Belgian multidisciplinary meeting on urological cancers held in Brussels, March 29th 2014
-
Congress highlights: ESMO 2014 special edition: highlights in genitourinary cancer